Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia

Blood Purification

Volumn 41, Issue 4, 2016, Pages 317-323

  Bonan, Natalia Borges ^a   Steiner, Thiago M ^a   Kuntsevich, Viktoriya ^c,d   Virzì, Grazia Maria ^e   Azevedo, Marina ^a   Nakao, Lia Sumie ^b   Barreto, Fellype Carvalho ^a   Ronco, Claudio ^e   Thijssen, Stephan ^c   Kotanko, Peter ^c,d   Pecoits Filho, Roberto ^a   Moreno Amaral, Andréa N ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c RENAL RESEARCH INSTITUTE   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

^e SAN BORTOLO HOSPITAL   (Italy)

Author keywords

CD14++ CD16+ monocytes; Eryptosis; Erythrophagocytosis; Renal anemia; Uremic toxicity

Indexed keywords

ACETYLCYSTEINE; CD14 ANTIGEN; CD16 ANTIGEN; REACTIVE OXYGEN METABOLITE; ANTISERUM; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; SCAVENGER;

ADULT; ANEMIA; ARTICLE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYPTOSIS; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROPHAGOCYTOSIS; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS PATIENT; HUMAN; MALE; MONOCYTE; MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; UREMIA; ADOLESCENT; AGED; ANTAGONISTS AND INHIBITORS; BLOOD; CASE CONTROL STUDY; COCULTURE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEMODIALYSIS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHAGOCYTOSIS; PRIMARY CELL CULTURE; RENAL INSUFFICIENCY, CHRONIC; VERY ELDERLY;

ACETYLCYSTEINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ANTIGENS, CD14; CASE-CONTROL STUDIES; COCULTURE TECHNIQUES; ERYPTOSIS; ERYTHROCYTES; FEMALE; FREE RADICAL SCAVENGERS; GENE EXPRESSION REGULATION; GPI-LINKED PROTEINS; HUMANS; IMMUNE SERA; MALE; MIDDLE AGED; MONOCYTES; PHAGOCYTOSIS; PRIMARY CELL CULTURE; REACTIVE OXYGEN SPECIES; RECEPTORS, IGG; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; UREMIA;

EID: 84957900359     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000443784     Document Type: Article

References (21)

1. Ly J, Marticorena R, Donnelly S: Red blood cell survival in chronic renal failure. Am J Kidney Dis 2004; 44: 715-719.
2. Joske RA, McAlister JM, Prankerd TA: Isotope investigations of red cell production and destruction in chronic renal disease. Clin Sci (Lond) 1956; 15: 511-522.
3. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F: Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005; 15: 195-202.
4. Bonomini M, Sirolli V, Reale M, Arduini A: Involvement of phosphatidylserine exposure in the recognition and phagocytosis of uremic erythrocytes. Am J Kidney Dis 2001; 37: 807-814.
5. Passlick B, Flieger D, Ziegler-Heitbrock HW: Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 1989; 74: 2527-2534.
6. Ziegler-Heitbrock HW, Fingerle G, Strobel M, Schraut W, Stelter F, Schutt C, Passlick B, Pforte A: The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993; 23: 2053-2058.
7. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, Hart DN, Leenen PJ, Liu YJ, MacPherson G, Randolph GJ, Scherberich J, Schmitz J, Shortman K, Sozzani S, Strobl H, Zembala M, Austyn JM, Lutz MB: Nomenclature of monocytes and dendritic cells in blood. Blood 2010; 116:e74-e80.
8. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, Ziegler-Heitbrock HW: The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993; 82: 3170-3176.
9. Krychtiuk KA, Kastl SP, Pfaffenberger S, Lenz M, Hofbauer SL, Wonnerth A, Koller L, Katsaros KM, Pongratz T, Goliasch G, Niessner A, Gaspar L, Huber K, Maurer G, Dostal E, Wojta J, Oravec S, Speidl WS: Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease. PLoS One 2015; 10:e0123367.
10. Heine GH, Ulrich C, Seibert E, Seiler S, Marell J, Reichart B, Krause M, Schlitt A, Kohler H, Girndt M: CD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patients. Kidney Int 2008; 73: 622-629.
11. Rogacev KS, Seiler S, Zawada AM, Reichart B, Herath E, Roth D, Ulrich C, Fliser D, Heine GH: CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease. Eur Heart J 2011; 32: 84-92.
12. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 suppl 1):S1-S266.
13. Ziegler-Heitbrock L, Hofer TP: Toward a refined definition of monocyte subsets. Front Immunol 2013; 4: 23.
14. Stinghen AE, Goncalves SM, Martines EG, Nakao LS, Riella MC, Aita CA, Pecoits-Filho R: Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract 2009; 111:c117-c126.
15. Nockher WA, Scherberich JE: Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect Immun 1998; 66: 2782-2790.
16. Lang E, Qadri SM, Lang F: Killing me softly-suicidal erythrocyte death. Int J Biochem Cell Biol 2012; 44: 1236-1243.
17. Bonomini M, Sirolli V, Settefrati N, Dottori S, Di Liberato L, Arduini A: Increased erythrocyte phosphatidylserine exposure in chronic renal failure. J Am Soc Nephrol 1999; 10: 1982-1990.
18. Ahmed MS, Abed M, Voelkl J, Lang F: Triggering of suicidal erythrocyte death by uremic toxin indoxyl sulfate. BMC Nephrol 2013; 14: 244.
19. Ahmed MS, Langer H, Abed M, Voelkl J, Lang F: The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013; 37: 158-167.
20. Nangaku M, Eckardt KU: Pathogenesis of renal anemia. Semin Nephrol 2006; 26: 261-268.
21. Ziegler-Heitbrock L: The CD14+ CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 2007; 81: 584-592.